Skip to content

The talk about RB

Who is saying what about RB? Here's a selection of some of the RB stories making the news.

India Could Become A Top Three Global Market Says RB Global CEO
"[Rakesh] Kapoor says he hopes to see India become one of RB’s top three markets in the next five years, possible even that it may closely compete with the U.S. and U.K. markets for second place. It’s already one of the company’s top 10 sales markets, a position it didn’t hold five years ago."
Forbes, 21 September 2015
> Read full article

RB beats first-half profit predictions with a bang
"A 'supercharged' first-half performance by RB has helped the maker of Cillit Bang and Nurofen to beat expectations and push up its guidance for the full year. The consumer goods group, which also makes Durex condoms, Dettol and Vanish stain remover, said that its like-for-like revenue was up by 5 per cent at £4.3 billion during the first half."
The Times, 28 July 2015
> Read full article

Upbeat RB lifts growth forecast on better consumer sentiment
"Rakesh Kapoor, chief executive, said he had pushed the forecast back up because of strong like-for-like growth in net revenues of 5 per cent in the first half. RB had a strong pipeline of products in the second half that would support further growth, he said."
Financial Times, 27 July 2015
> Read full article

'Favourable' flu season helps Nurofen and Strepsils maker Reckitt Benckiser lift results and sales
"RB is trying to boost its presence in the consumer health sector, which has been growing fast amid increased demand for over-the-counter remedies and health products. This has come thanks to a greater awareness of health, aging populations in developed markets and rising incomes and urbanisation in emerging markets."
This Is Money, 27 July 2015
> Read full article

Consistent income is healthy indicator
"What is most noticeable about [RB's] performance over the past year or so is its consistency. Most global consumer groups have stumbled in one market or another, but RB…has moved revenues ahead in all three of its core divisions."
The Times, 27 July 2015
> Read full article

Strong healthcare brands boost Reckitt Benckiser sales
"RB reported forecast-beating quarterly sales thanks to a strong performance from its high-margin healthcare and hygiene brands, and growth across all geographical regions."
Financial Times, 24 April 2015
> Read full article

"As part of a “Stop Diarrhoea” program run by the non-profit Save the Children, a biodegradable toilet powder that speeds up the breakdown of excrement has been developed by RB — makers of toilet cleaning products such as Harpic and Dettol."
Wall Street Journal, 26 March 2015
> Read full article

“'The consumer healthcare landscape is going to change enormously in the next 10 years. What you see today is not what you will see tomorrow,' according to Sharon James, head of research and development at RB."
OTC Bulletin, 7 November 2014
> View full article (PDF)
"Mr Kapoor said he expected margins to rise in the second half and full- year targets to be hit, with revenue at the 'lower end' of the 4pc to 5pc forecast range. RB remains a massive player in its core businesses and has the brands, management and expertise to strengthen its place in the sector along with the financial firepower to back this."
Daily Telegraph, 22 October 2014 (print edition)

Ditching the drugs puts focus on health
"Third-quarter figures give a clear enough idea why the pharmaceuticals business is being spun off, allowing RB to concentrate on higher-growth health brands, such as Nurofen and Scholl."
The Times, 22 October 2014
> Read full article

How RB became 'digital at heart'
Marketing chief Laurent Faracci details how interactive affects everything from RB's agency relationships to how it recruits executives and works with retailers.
Advertising Age, 16 September 2014
> Read full article

RB boss makes his name with Mucinex and K-Y Jelly
"Kapoor has outlined a strategy of expanding sales of over-the-counter brands such as Mucinex decongestants and Durex condoms. While that business accounted for a quarter of 2011 sales – about the same as the unit that includes laundry products – consumer health has better prospects. The $200 billion industry is expanding fast due to increasing self-medication among an aging population and drugs moving off prescription."
Bloomberg, 18 August 2014
> Read full article

Durex India launches initiatives to address the taboo subject of sexual wellbeing
""In an environment where sex is not discussed candidly, there is a need of having an easily accessible source of credible information, which helps consumers understand this space better," said Chander Mohan Sethi, SVP South East Asia. To that effect, Durex India recently launched an online store where people can go and buy condoms without feeling embarrassed at the counter. "The content is useful, not only for couples looking to revive their relationship, but also for teenagers explor­ing their sexuality," Sethi explained."
Time Out Mumbai, 28 February 2014
> Read full article 

Maker of brands including Dettol and Nurofen expects revenues to rise as firm increases sales of its 19 'Powerbrands'
"Announcing its full-year results for 2013, RB posted like-for-like sales, excluding drugs, up 4% in the fourth quarter, slightly less than the 4.2% rise forecast by analysts. Including revenue from acquisitions, sales were up 7% – ahead of the company's target.

Chief executive Rakesh Kapoor said he expected revenues, excluding drugs sales, to rise between 4% and 5% in the current year as the company increases sales of its 19 so-called powerbrands such as Harpic, Vanish and Strepsils."
The Guardian, 12 February 2014
> Read full article

"RB has pegged its future on health and hygiene, saying higher growth products such as vitamins and branded medicines had helped push sales above €10bn for the first time in 2013."
Financial Times, 12 February 2014
> Read full article

RB shrugs off fears for emerging markets slowdown
"Stripping out the pharmaceuticals arm, operating profits rose 7% to £2.19 billion on revenue of £10 billion. Highlighted as strong performers were both its health and hygiene arms. In health, brands such as Durex, Nurofen, Scholl footcare and Gaviscon did well, although Strepsils and Mucinex performed less well against tough comparatives a year earlier. In hygiene, it was Veet, Dettol and Lysol that did best, particularly in the last quarter of the year.

Credit Suisse analysts were impressed with the numbers, saying they were a “modest beat” on expectations. In a note to clients, they wrote: “A case of Reckitt beginning to rediscover its mojo?”"
London Evening Standard, 12 February 2014
> Read full article

RB sees more sales growth, names chairman for pharma unit

"RB, whose wide range of household, health and personal brands include Lysol disinfectant and Durex condoms earlier reported that fourth-quarter like-for-like sales excluding its drug business rose 4 percent. The consensus forecast from analysts in a company-supplied survey was for an increase of 4.2 percent."
Reuters, 12 February 2014
> Read full article

> View older articles

Get involved with RB

  • facebook
  • Linked In
  • twitter
  • You Tube
  • Google Plus
  • blog
  • fmcg

UK's Most Admired Companies Winner 2014/15
We maintain a long running partnership with RB in automatic dishwashing because we know the market leaders also excel in innovations - Christoph Kilian, VP Product Marketing, Product Area, Dishwasher, Bosch and Siemens, Homeappliances GroupThe company (shows) an amazing contrast to its most important competitors...Proctor and Gamble (and) Unilever We work together with RB because RB is a very innovative company and it's ideas are driven by consumer insights- Filip Francke, Head of Product Line Dish Care, Electrolux Home Products, Coporation NV
  • Lysol
  • Mucinex
  • Frenchs
  • Airwick
  • Nurofen
  • Vanish
  • Durex
  • Clearasil
  • Dettol
  • Cillet Bang
  • Strepsils
  • Scholl
  • Gaviscon
  • Mortein
  • Woolite
  • Veet
  • harpic
  • Calgon
  • Finish

This site uses cookies. By continuing to browse the site without disabling them, you consent to our use of cookies. To learn more about the types of cookies we use, please view our cookie policy.

Continue using the site